Products for Research Use Only

AAI-101

CAT: 0498-bs-7133C-01Size: 2 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0498-bs-7133C-01Size:2 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
1001404-83-6
Conjugation
Unconjugated
Purity
98
Buffer
Powder
Solubility
Soluble in DMSO
Smiles
C[N+]1C=CN(C[C@@]2(C)[C@H](C([O-])=O)N3[C@@H](CC3=O)S2(=O)=O)N=1
Molecular Formula
C11 H14 N4 O5 S
Molecular Weight
314.32
InChI
InChI=1S/C11H14N4O5S/c1-11 (6-14-4-3-13 (2) 12-14) 9 (10 (17) 18) 15-7 (16) 5-8 (15) 21 (11,19) 20/h3-4,8-9H,5-6H2,1-2H3/t8-,9+,11+/m1/s1
Storage Conditions
Store in dry, dark place at -20C for 1 year.
Shelf Life
1 year
Appearance
Solid Power.

1001404-83-6

PubChem
cas1001404-83-6
modify2026-05-17
descriptionEnmetazobactam is a penicillanic acid sulfone extended-spectrum beta (β)-lactamase (ESBL) inhibitor. Because ESBL enzymes can hydrolyze important antibiotics such as penicillins, broad-spectrum cephalosporins and monobactams, ESBL-producing bacteria poses challenges in the treatment of serious infections. The combination product of enmetazobactam and [cefepime] was first approved by the FDA on February 23, 2024, for the treatment of complicated urinary tract infections. Enmetazobactam is used as cefepime-sparing therapy by preventing its breakdown by ESBL.
synonyms
Enmetazobactam1001404-83-6AAI-101OCID-509080VUN7L00C
(2S,3S,5R)-3-Methyl-3-[(3-methyltriazol-3-ium-1-yl)methyl]-4,4,7-trioxo-4lambda6-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
EXBLIFEP COMPONENT ENMETAZOBACTAM
(2S,3S,5R)-3-Methyl-3-((3-methyltriazol-3-ium-1-yl)methyl)-4,4,7-trioxo-4^6-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate
1H-1,2,3-Triazolium, 3-(((2S,3S,5R)-2-carboxy-3-methyl-4,4-dioxido-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-3-yl)methyl)-1-methyl-, inner salt
(2S,3S,5R)-3-methyl-3-((3-methyltriazol-3-ium-1-yl)methyl)-4,4,7-trioxo-4lambda6-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate
+ 15 more
PubChem LinkClick here